Chimeric Therapeutics Seeks New ASX Quotation
Company Announcements

Chimeric Therapeutics Seeks New ASX Quotation

Chimeric Therapeutics Ltd. (AU:CHM) has released an update.

Chimeric Therapeutics Limited has announced a new application for the quotation of securities, seeking to have 6,841,387 of its ordinary fully paid shares quoted on the ASX under the code CHM. The application was formally submitted on August 30, 2024, as per the details provided in the company’s recent regulatory filing.

For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App